Brainstorm Cell Therapeutics Inc. received a notice from Nasdaq stating that its Market Value of Listed Securities (MVLS) was below the minimum requirement for continued listing.
AI Assistant
BRAINSTORM CELL THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.